ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
API referenceFor AI assistants

Trial · NCT03617536

Adverse events200

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

141 to 160 of 200

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousHyperkalaemiaMetabolism and nutrition disordersCR845 0.25 mg Oral Tablet169
seriousHyperkalaemiaMetabolism and nutrition disordersCR845 0.5 mg Oral Tablet066
seriousHyperkalaemiaMetabolism and nutrition disordersCR845 1 mg Oral Tablet067
seriousHyperkalaemiaMetabolism and nutrition disordersPlacebo Oral Tablet167
seriousHypoglycaemiaMetabolism and nutrition disordersCR845 0.25 mg Oral Tablet269
seriousHypoglycaemiaMetabolism and nutrition disordersCR845 0.5 mg Oral Tablet066
seriousHypoglycaemiaMetabolism and nutrition disordersCR845 1 mg Oral Tablet067
seriousHypoglycaemiaMetabolism and nutrition disordersPlacebo Oral Tablet067
seriousDiabetic ketoacidosisMetabolism and nutrition disordersCR845 0.25 mg Oral Tablet069
seriousDiabetic ketoacidosisMetabolism and nutrition disordersCR845 0.5 mg Oral Tablet066
seriousDiabetic ketoacidosisMetabolism and nutrition disordersCR845 1 mg Oral Tablet167
seriousDiabetic ketoacidosisMetabolism and nutrition disordersPlacebo Oral Tablet067
seriousHypernatraemiaMetabolism and nutrition disordersCR845 0.25 mg Oral Tablet069
seriousHypernatraemiaMetabolism and nutrition disordersCR845 0.5 mg Oral Tablet166
seriousHypernatraemiaMetabolism and nutrition disordersCR845 1 mg Oral Tablet067
seriousHypernatraemiaMetabolism and nutrition disordersPlacebo Oral Tablet067
seriousCostochondritisMusculoskeletal and connective tissue disordersCR845 0.25 mg Oral Tablet169
seriousCostochondritisMusculoskeletal and connective tissue disordersCR845 0.5 mg Oral Tablet066
seriousCostochondritisMusculoskeletal and connective tissue disordersCR845 1 mg Oral Tablet067
seriousCostochondritisMusculoskeletal and connective tissue disordersPlacebo Oral Tablet067

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03617536/events?page=8

API referenceFor AI assistants